January 23,2017

STH Advisory Committee Publishes 2016 Recommendations

STH Advisory Committee Publishes 2016 Recommendations

Read the full summary notes and recommendations here.

The STH Advisory Committee continues its role as a primary voice shaping STH programming and research. In support of the 2020 World Health Organization (WHO) goal of eliminating STH as a public health problem, the Committee considers parasitologic monitoring as “the most important way to assess progress toward this goal.” While 59% of all children requiring preventive chemotherapy (i.e. deworming medication) received treatment in 2015,[1] the extent to which the treatment coverage that was achieved has affected national and sub-national prevalence and intensity of infection remains unclear. This fact highlights the importance of the Committee’s emphasis on monitoring prevalence and intensity, as eliminating STH as public health problem is defined by less than 1% moderate-to-heavy intensity infection in at-risk children.

With WHO continuing to consider revisions to the current global STH control strategic plan, the Committee held its annual meeting in October 2016 to review global progress, identify challenges, and provide recommendations on achieving the WHO goal of eliminating STH as a public health problem. Hosted by the Swiss Tropical and Public Health Institute, 30 representatives from 20 organizations and institutions were in attendance. Participants represented researchers, program implementers, WHO, and pharmaceutical partners. During the two-day meeting, attendees discussed how to catalyze advances in STH diagnostic methods, the design of parasitologic surveys, and guidelines for national STH programs to implement and evaluate their progress toward the 2020 WHO goal. The STH Advisory Committee published the entirety of its 2016 recommendations late last year.

Children Without Worms serves as the secretariat to the STH Advisory Committee, which is a group of independent STH experts with a broad range of experience including child health, clinical medicine, education, epidemiology, parasitology, public health program implementation, spatial statistics, and water, sanitation and hygiene (WASH). As the technical and scientific arm of the STH Coalition, the STH Advisory Committee advises the Coalition, Johnson & Johnson (J&J), GlaxoSmithKline (GSK),[2] the WHO Neglected Tropical Disease (NTD) Strategic and Technical Advisory Group (STAG), and other constituencies.

 


[1] World Health Organization. Weekly epidemiological record. 2016, 91, 585-600.

[2] GLAXOSMITHKLINE, GSK and the GSK Logo are trademarks of the GSK group of companies and are used with the permission of GSK.

Share This Article